Cision PR Newswire

Akeso’s AK157D1 (B7-H3 ADC) Cleared for Phase I Trial in Solid Tumors, Adding a Third Differentiated ADC to Its Pipeline

HONG KONG, Aug. 21, 2026 /PRNewswire/ -- Akeso, Inc. (9926.HK) ("Akeso" or the "Company") today announced that its investigational next-generation B7-H3-targeting antibody-drug conjugate (ADC), AK157D1, has received clinical trial clearance from the Center for Drug Evaluation (CDE) of China's National Medical Products Administration (NMPA). The clearance allows initiation of...

JIN MEDICAL INTERNATIONAL LTD. Reports First Half of Fiscal Year 2026 Financial Results

CHANGZHOU, China, Aug. 5, 2026 /PRNewswire/ -- JIN MEDICAL INTERNATIONAL LTD. (Nasdaq: ZJYL) ("Jin Medical", and together with all its subsidiaries and consolidated entities, the...

Elong Power Holding Limited Announces Closing of US$1.38 Million Public Offering

BEIJING, Aug. 5, 2026 /PRNewswire/ -- Elong Power Holding Limited (Nasdaq: ELPW) ("Elong Power" or the "Company"), a comprehensive provider dedicated to the R&D,...

Agthia Reports Stronger H1 2026 Financial Position and Raises Interim Dividend 14.4%

ABU DHABI, UAE, Aug. 5, 2026 /PRNewswire/ -- Agthia Group PJSC (AGTHIA: UH), one of the region's leading food and beverage companies, today reported its first-half and...

Agthia Reports Stronger H1 2026 Financial Position and Raises Interim Dividend 14.4%

ABU DHABI, UAE, Aug. 5, 2026 /PRNewswire/ -- Agthia Group PJSC (AGTHIA: UH), one of the region's leading food and beverage companies, today reported its first-half and...

Ke Bi Appointed Global Chief Executive Officer of FranklinWH

Veteran executive to drive international expansion and build on company momentum in the U.S. residential energy storage market SAN JOSE, Calif., Aug. 5,...